Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment ; volume:269 ; number:9 ; day:1 ; month:8 ; year:2022 ; pages:5192-5193 ; date:9.2022
Journal of neurology ; 269, Heft 9 (1.8.2022), 5192-5193, 9.2022
- Classification
-
Medizin, Gesundheit
- Creator
-
Kreft, Karim L.
Robertson, Neil P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-022-11300-x
- URN
-
urn:nbn:de:101:1-2022102700491073095537
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kreft, Karim L.
- Robertson, Neil P.
- SpringerLink (Online service)
Other Objects (12)
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
Molecular biomarkers in multiple sclerosis
Initiating learning
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Digital biomarkers for immunotherapy in multiple sclerosis patients
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Two independent epigenetic biomarkers predict survival in neuroblastoma
Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
Molecular biomarkers in multiple sclerosis
Initiating learning
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Digital biomarkers for immunotherapy in multiple sclerosis patients
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Two independent epigenetic biomarkers predict survival in neuroblastoma
Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis
Sirtuin3 and Sirtuin7 are promising biomarkers in systemic sclerosis
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis
Molecular biomarkers in multiple sclerosis
Initiating learning
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Fluid biomarkers for amyotrophic lateral sclerosis: a review
Digital biomarkers for immunotherapy in multiple sclerosis patients
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers
Two independent epigenetic biomarkers predict survival in neuroblastoma
Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates
Biomarkers inform clinical trials and pathogenesis in systemic sclerosis